NYSE:PBHPrestige Consumer Healthcare Stock Price, Forecast & News

Prestige Consumer Healthcare's stock was trading at $35.91 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, PBH shares have increased by 5.2% and is now trading at $37.77.
View which stocks have been most impacted by COVID-19.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Prestige Consumer Healthcare in the last year. There are currently 6 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Prestige Consumer Healthcare.

Prestige Consumer Healthcare is scheduled to release its next quarterly earnings announcement on Thursday, October 29th 2020.
View our earnings forecast for Prestige Consumer Healthcare.

Prestige Consumer Healthcare Inc (NYSE:PBH) posted its quarterly earnings data on Thursday, August, 6th. The company reported $0.86 earnings per share for the quarter, beating analysts' consensus estimates of $0.70 by $0.16. The business had revenue of $229.40 million for the quarter, compared to analyst estimates of $221.27 million. Prestige Consumer Healthcare had a net margin of 15.84% and a return on equity of 13.81%. The company's revenue for the quarter was down 1.2% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.65 EPS.
View Prestige Consumer Healthcare's earnings history.

Prestige Consumer Healthcare updated its second quarter earnings guidance on Thursday, August, 6th. The company provided earnings per share guidance of $0.70 or more for the period, compared to the Thomson Reuters consensus EPS estimate of $0.71. The company issued revenue guidance of $225 million or more, compared to the consensus revenue estimate of $236.06 million.

7 brokers have issued 12-month price targets for Prestige Consumer Healthcare's stock. Their forecasts range from $43.00 to $97.00. On average, they anticipate Prestige Consumer Healthcare's stock price to reach $69.00 in the next year. This suggests a possible upside of 82.7% from the stock's current price.
View analysts' price targets for Prestige Consumer Healthcare.

News headlines about PBH stock have been trending negative this week, according to InfoTrie. InfoTrie identifies positive and negative press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Prestige Consumer Healthcare earned a media sentiment score of -2.4 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days.
View the latest news about Prestige Consumer Healthcare.

Prestige Consumer Healthcare saw a increase in short interest in June. As of June 15th, there was short interest totaling 4,880,000 shares, an increase of 22.6% from the May 31st total of 3,980,000 shares. Based on an average daily volume of 476,100 shares, the days-to-cover ratio is currently 10.2 days. Currently, 9.8% of the company's stock are sold short.
View Prestige Consumer Healthcare's Short Interest.

Some companies that are related to Prestige Consumer Healthcare include Estee Lauder Companies (EL), Herbalife Nutrition (HLF), Nu Skin Enterprises (NUS), Medifast (MED), USANA Health Sciences (USNA), Inter Parfums (IPAR), Revlon (REV), Nature's Sunshine Products (NATR) and Veru (VERU).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Prestige Consumer Healthcare investors own include AbbVie (ABBV), Gilead Sciences (GILD), Pfizer (PFE), AT&T (T), Wells Fargo & Co (WFC), IBM (IBM), Intel (INTC), Boeing (BA), Enterprise Products Partners (EPD) and Micron Technology (MU).

Prestige Consumer Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "PBH."

Prestige Consumer Healthcare's stock is owned by a variety of institutional and retail investors. Top institutional investors include Macquarie Group Ltd. (3.54%), FMR LLC (2.37%), Goldman Sachs Group Inc. (2.23%), Fisher Asset Management LLC (1.58%), LSV Asset Management (1.43%) and Bank of New York Mellon Corp (1.29%). Company insiders that own Prestige Consumer Healthcare stock include Paton Brett, Ronald M Lombardi and Timothy Connors.
View institutional ownership trends for Prestige Consumer Healthcare.

PBH stock was sold by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., NN Investment Partners Holdings N.V., NN Investment Partners Holdings N.V., Dalton Greiner Hartman Maher & Co., Skyline Asset Management LP, State of Tennessee Treasury Department, Dupont Capital Management Corp, and Fisher Asset Management LLC.
View insider buying and selling activity for Prestige Consumer Healthcare.

PBH stock was purchased by a variety of institutional investors in the last quarter, including Prudential Financial Inc., Nordea Investment Management AB, UBS Group AG, Macquarie Group Ltd., First Trust Advisors LP, Russell Investments Group Ltd., Mutual of America Capital Management LLC, and Duality Advisers LP.
View insider buying and selling activity for Prestige Consumer Healthcare.

Shares of PBH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of PBH stock can currently be purchased for approximately $37.77.

Prestige Consumer Healthcare has a market capitalization of $1.90 billion and generates $963.01 million in revenue each year. The company earns $142.28 million in net income (profit) each year or $2.96 on an earnings per share basis. Prestige Consumer Healthcare employs 530 workers across the globe.

The official website for Prestige Consumer Healthcare is www.prestigebrands.com.

Prestige Consumer Healthcare's mailing address is 660 WHITE PLAINS ROAD SUITE 250, TARRYTOWN NY, 10591. The company can be reached via phone at 914-524-6800 or via email at [email protected]